Anupam Rasayan signs contract worth Rs 984 crore with Japanese firm for supply of new product
Product is being manufactured for the first time in India and it is in line with the government's 'make in India' policy, said the company's Managing Director Anand Desai.

Anand Desai said sales realisation for this molecule will be one of the highest for the company. (Representative image from Pixabay)